The cost of health care for children and adults with sickle cell disease

The cost of health care for children and adults with sickle cell disease
复制标题

DOI:
10.1002/ajh.21408
复制
发表时间:
2009-06-01
影响因子:
12.8
通讯作者:
Hartzema, Abraham G.
Hartzema, Abraham G.
中科院分区:
医学1区
文献类型:
--
作者:
Kauf, Teresa L.;Coates, Thomas D.;Hartzema, Abraham G.

文献摘要

被引文献

相似文献

尽管镰状细胞病(SCD)的特点是医疗资源的高利用率,但SCD患者的全部护理费用,包括与SCD无直接关系的护理费用,尚不清楚。本研究的目的是估计SCD儿童和成人人群的医疗保健总成本。我们使用2001-2005年期间参加佛罗里达医疗补助计划的诊断为SCD的个人的数据,根据患者使用医疗保健时的年龄估计每患者月的总成本、SCD相关成本和非SCD相关成本。在4,294名患者样本中,总医疗保健费用通常随年龄增长而上升,0-9岁和50-64岁年龄组的患者月人均医疗费用分别从892美元增加到2,562美元。每个患者月的平均费用为1,389美元。总体而言,51.8%的护理与SCD直接相关,其中大部分(80.5%)与住院治疗相关。值得注意的是,非SCD相关成本远高于美国普通人群报告的成本。这些结果表明,每名SCD患者的折扣(3%的折扣率)终身护理成本平均为460,151美元。旨在预防SCD并发症和避免住院治疗的干预措施可能会减少该疾病的重大经济负担。Am. J. Hematol. 84:323-327,2009. (C)2009威利-利斯公司
Although sickle cell disease (SCD) is marked by high utilization of medical resources, the full cost of care for patients with SCD, including care not directly related to SCD, is unknown. The purpose of this study was to estimate the total cost of medical care for a population of children and adults with SCD. We used data from individuals diagnosed with SCD enrolled in the Florida Medicaid program during 2001-2005 to estimate total, SCD-related, and non-SCD-related cost per patient-month based on patient age at the time of health care use. Across the 4,294 patient samples, total health care costs generally rose with age, from $892 to $2,562 per patient-month in the 0-9- and 50-64-year age groups, respectively. Average cost per patient-month was $1,389. Overall, 51.8% of care was directly related to SCD, the majority of which (80.5%) was associated with inpatient hospitalizations. Notably, non-SCD-related costs were substantially higher than those reported for the general US population. These results suggest a discounted (3% discount rate) lifetime cost of care averaging $460,151 per patient with SCD. Interventions designed to prevent SCD complications and avoid hospitalizations may reduce the significant economic burden of the disease. Am. J. Hematol. 84:323-327, 2009. (C) 2009 Wiley-Liss, Inc.